Markus Puhlmann
Director Técnico/Científico/I+D en PERSPECTIVE THERAPEUTICS, INC. .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Markus Puhlmann
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Markus Puhlmann
Antiguos cargos conocidos de Markus Puhlmann.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2019 | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Formación de Markus Puhlmann.
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Alemania | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Markus Puhlmann
- Experiencia